Cargando…

Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients

Deregulation of long non-coding RNAs (lncRNAs) expression has been proven to be involved in the development and progression of cancer. However, expression pattern and prognostic value of lncRNAs in breast cancer recurrence remain unclear. Here, we analyzed lncRNA expression profiles of breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Meng, Zhong, Lei, Xu, Wanying, Sun, Yifan, Zhang, Zhaoyue, Zhao, Hengqiang, Yang, Lei, Sun, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977495/ https://www.ncbi.nlm.nih.gov/pubmed/27503456 http://dx.doi.org/10.1038/srep31038

Ejemplares similares

Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma
por: Zhou, Meng, et al.
Publicado: (2017)

Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer
por: Zhou, Meng, et al.
Publicado: (2016)

Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer
por: Zhou, Meng, et al.
Publicado: (2016)

A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma
por: Sun, Jie, et al.
Publicado: (2016)

Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma
por: Zhou, Meng, et al.
Publicado: (2016)

A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma
por: Zhou, Meng, et al.
Publicado: (2018)

Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma
por: Zhou, Meng, et al.
Publicado: (2015)

Long non-coding RNA TTTY14 promotes cell proliferation and functions as a prognostic biomarker in testicular germ cell tumor
por: Cao, Jian, et al.
Publicado: (2023)

Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Recurrence in Patients with Cervical Cancer
por: Zhang, Yan, et al.
Publicado: (2020)

Long non-coding RNAs as novel prognostic biomarkers for breast cancer in Egyptian women
por: El-Helkan, Basma, et al.
Publicado: (2022)

Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer
por: Zhou, Meng, et al.
Publicado: (2018)

Prognostic biomarkers related to breast cancer recurrence identified based on Logit model analysis
por: Zhou, Xiaoying, et al.
Publicado: (2020)

Long non-coding RNA TUG1 as a potential prognostic biomarker in human cancers: a meta-analysis
por: Ma, Peng-Ju, et al.
Publicado: (2017)

Long non-coding RNA LINC02613 is a prognostic biomarker for breast cancer and correlates with the cell cycle and immune infiltration based on TCGA data
por: Cui, Mengyao, et al.
Publicado: (2022)

Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects
por: Lu, Cuicui, et al.
Publicado: (2021)

A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients
por: Sun, Jie, et al.
Publicado: (2015)

Metabolism-related long non-coding RNAs (lncRNAs) as potential biomarkers for predicting risk of recurrence in breast cancer patients
por: Ma, Jian-ying, et al.
Publicado: (2021)

Correction to: Prognostic biomarkers related to breast cancer recurrence identified based on Logit model analysis
por: Zhou, Xiaoying, et al.
Publicado: (2020)

Long non-coding RNA Linc00261 as a novel potential diagnostic and prognostic biomarker for gallbladder cancer
por: Niu, Jia-Zeng, et al.
Publicado: (2020)

Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer
por: Wang, Yaozong, et al.
Publicado: (2019)

Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
por: Jeong, Hasong, et al.
Publicado: (2019)

Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor
por: Guo, Jie, et al.
Publicado: (2022)

An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer
por: Lian, Penghu, et al.
Publicado: (2019)

Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis
por: Fan, Yang-Hua, et al.
Publicado: (2017)

A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients
por: Zhong, Lei, et al.
Publicado: (2017)

Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma
por: Tang, Junwei, et al.
Publicado: (2015)

Identification of prognostic biomarkers of prostate cancer with long non-coding RNA-mediated competitive endogenous RNA network
por: Ye, Guomei, et al.
Publicado: (2019)

Identification of Long Non-Coding RNA MIR4435-2HG as a Prognostic Biomarker in Bladder Cancer
por: Hu, Zhiquan, et al.
Publicado: (2022)

Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer
por: Zhou, Meng, et al.
Publicado: (2016)

Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer
por: Saus, Ester, et al.
Publicado: (2016)

Long non-coding RNAs as prognostic biomarkers in papillary renal cell carcinoma
por: Yang, Feilong, et al.
Publicado: (2019)

Identification and validation of tumor microenvironment-related prognostic biomarkers in breast cancer
por: Zhong, Shanliang, et al.
Publicado: (2021)

Long non-coding RNAs as prognostic markers in human breast cancer
por: Liu, Hairong, et al.
Publicado: (2016)

Prognostic value of routine laboratory variables in prediction of breast cancer recurrence
por: Zhu, Zhu, et al.
Publicado: (2017)

Prognostic biomarker identification and tumor classification in breast cancer patients by methylation and transcriptome analysis
por: Zhong, Xiongdong, et al.
Publicado: (2021)

Robust edge-based biomarker discovery improves prediction of breast cancer metastasis
por: Adnan, Nahim, et al.
Publicado: (2020)

Identification of long non-coding RNA-mediated transcriptional dysregulation triplets reveals global patterns and prognostic biomarkers for ER(+)/PR(+), HER2(−) and triple negative breast cancer
por: Du, Zhengwei, et al.
Publicado: (2019)

Long non‐coding RNAs and their targets as potential biomarkers in breast cancer
por: Khalid, Maryam, et al.
Publicado: (2021)

The potential of glutamine metabolism-related long non-coding RNAs (lncRNAs) as prognostic biomarkers in multiple myeloma patients
por: Zhong, Yun, et al.
Publicado: (2022)

Prognostic value of long non-coding RNA signatures in bladder cancer
por: He, Anbang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7vifrqovriekrhugiqfsh47nqc